CIK 0001006281 · Non-accelerated filer<br>Smaller reporting company
Protalix BioTherapeutics, Inc.
Sign in to watch- Ticker
- PLX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 650643773
- Phone
- 201-696-9345
- Business address
- 2 UNIVERSITY PLAZA, SUITE 100, HACKENSACK, NJ, 07601
- Former names
- ORTHODONTIX INC, EMBASSY ACQUISITION CORP
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Director nominations
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CT ORDER Other Confidential Order
- 4 Insider Changes in Ownership
- 10-Q/A Report 10-Q/A
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- 8-K Event Other events
- S-3 Offering Registration Statement
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 23 of 49 · 974 filings